Roche’s Polivy combination study shows positive outcomes in treating DLBCL
The Phase 3 trial evaluated the efficacy, safety and pharmacokinetics of Polivy in combination with R-CHP, compared to…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Aug 21
The Phase 3 trial evaluated the efficacy, safety and pharmacokinetics of Polivy in combination with R-CHP, compared to…
09 Aug 21
The FDA approval is based on positive Phase 3 data showing improvements in key disease burden measures and…
09 Aug 21
With the regulatory approval, J&J moves a step closer to supplying the first single-dose Covid-19 vaccine dose to…
06 Aug 21
We focus on decentralisation and the challenges involved in operating clinical trials in a virtual setting.
06 Aug 21
With the acquisition, Bayer will obtain full rights to Vividion’s discovery platform that includes chemoproteomic screening technology, an…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Aug 21
Novavax along with its partner SII intend to obtain World Health Organization (WHO) emergency use listing (EUL) this…
05 Aug 21
SoftBank’s investment was driven by Roche’s subsidiary Genentech, which focuses on drug discovery and development, and is believed…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Aug 21
The randomised, placebo-controlled, double-blind Phase 2b/3 ALLEGRO trial met the primary efficacy endpoint of improving scalp hair regrowth,…
04 Aug 21
The acquisition of Translate Bio will help French drugmaker Sanofi to further advance the development of transformative medicines…
03 Aug 21
The FDA approval was based on efficacy and safety data from the Saphnelo clinical development programme, including two…